$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today

TG Therapeutics (NASDAQ:TGTX) has outperformed the market over the past 5 years by 9.05% on an annualized basis producing an average annual return of 22.44%. Currently, TG Therapeutics has a market

BenzingaJul 12 11:30 ET

Subdued Growth No Barrier To TG Therapeutics, Inc. (NASDAQ:TGTX) With Shares Advancing 29%

TG Therapeutics, Inc. (NASDAQ:TGTX) shares have continued their recent momentum with a 29% gain in the last month alone. Unfortunately, the gains of the last month did little to right the losses

Simply Wall StJul 11 08:09 ET

TG Therapeutics Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since September 2020 -- Data Talk

TG Therapeutics, Inc. ( TGTX ) is currently at $20.45, up $0.54 or 2.71% --Would be highest close since Jan. 9, 2024, when it closed at $21.01 --Currently up eight of the past nine days --Currently

Dow JonesJul 10 13:59 ET

TG Therapeutics (NASDAQ:TGTX) Delivers Shareholders Solid 15% CAGR Over 5 Years, Surging 6.6% in the Last Week Alone

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on a lighter note, a good company can see its share price rise well

Simply Wall StJun 22 08:01 ET

Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)

Yahoo FinanceJun 21 03:09 ET

TG Therapeutics(TGTX.US) Director Sells US$432.89K in Common Stock

$TG Therapeutics(TGTX.US)$ Director Lonial Sagar sold 25,933 shares of common stock on Jun 17, 20, 2024 at an average price of $16.69 for a total value of $432.89K.Source: Announcement What is stateme

moomoo NewsJun 20 18:51 ET